New product mix nurses Biocon back to health

Biocon has managed to heal the wound fast. India's largest biotechnology company, which straddles high-end drug research to generics, bet the wrong way on how the rupee will move against the dollar......

Drug firms go slow on overseas M&As

Outbound acquisitions by Indian drug companies slumped 67 per cent during the year as a global credit crunch squeezed liquidity. The less-than-anticipated results of a few big-ticket acquisitions......

Biocon acquires Germany's AxiCorp

India's premier biotechnology company Biocon Limited has achieved a major breakthrough in Europe by acquiring a majority stake in AxiCorp Pharmaceuticals, a leading German company. Disclosing the......

Banks reel under credit blues

Banks have been trimming interest rates in a bid to create demand. The latest to do so are State Bank of India and Canara Bank, which have pared their benchmark rates by 25 basis points. The......